Gene Therapy Market (3rd Edition), 2019-2030"
Roots Analysis is pleased to announce the publication of its recent study, titled, "Gene Therapy Market (3rd Edition), 2019-2030"
By: Roots Analysis
§ A detailed review of the overall landscape of gene therapies and genome editing therapies.
§ A discussion on the various types of viral and non-viral vectors.
§ A world map representation, depicting the most active geographies, and a bull's eye analysis, highlighting the distribution of clinical-stage pipeline candidates by phase of development, type of vector and type of therapy.
§ A discussion on the regulatory landscape related to gene therapies across various geographies.
§ Detailed profiles of marketed and phase II/III and gene therapies.
§ An elaborate discussion on the various commercialization strategies that can be adopted by drug developers for use across different stages of therapy development.
§ A review of various emerging technologies and therapy development platforms that are being used to design and manufacture gene therapies.
§ An in-depth analysis of the various patents that have been filed / granted related to gene therapies and genome editing therapies, since 2016.
§ An analysis of the various mergers and acquisitions that have taken place in this domain, highlighting the trend in the number of companies acquired between 2014-2019.
§ An analysis of the investments made at various stages of development in companies that are focused in this area, between 2014-2019.
§ An analysis of the big biopharma players engaged in this domain.
§ A case study on the prevalent and emerging trends related to vector manufacturing, with information on companies offering contract services for manufacturing vectors.
§ A discussion on the various operating models adopted by gene therapy developers for supply chain management.
§ An analysis of the various factors that are likely to influence the pricing of gene-based therapies.
§ A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
§ Key therapeutic areas
§ Autoimmune disorders
For more information please click on the following link:
Other Recent Offerings
1. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (3rd Edition), 2019-2030 (Focus on AAV, Adenoviral, Lentiviral, Retroviral, Plasmid DNA and Other Vectors) (https://www.rootsanalysis.com/
2. CAR-T Therapies Market (2nd Edition), 2019-2030
3. Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019 – 2030
Roots Analysis Private Limited
+1 (415) 800 3415